Gartner (IT) EVP Awarded Routine Equity Compensation Grant
GARTNER INC
Subscribe to track IT
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Gartner (IT) EVP Awarded Equity Grant
Company: GARTNER INC (IT) Form: 4 | Filed: 2026-02-09 Significance: Low
Insider: Kim Thomas Sang Title: EVP, Chief Legal Officer | Relationship: Officer
Transaction: • Type: Grant (Code A) • Securities: 2,687 RSUs & 16,113 SARs • Price: $0.00 (Grant) • Value: $0 (Grant) • Owned After: 2,687 RSUs & 16,113 SARs (separate holdings)
Key Insight: The EVP, Chief Legal Officer received a routine equity compensation package. The total underlying shares represent a negligible 0.026% of shares outstanding, indicating standard executive remuneration rather than a significant market event.
Market Context: These grants are part of a standard compensation plan with multi-year vesting schedules, designed to align insider interests with long-term shareholder value. The impact on the stock is expected to be neutral.
Comprehensive Analysis
SEC Filing Analysis: GARTNER INC (IT)
Executive Summary
- Trading Significance: Low
- Key Takeaway: The EVP, Chief Legal Officer received a routine executive compensation package consisting of Restricted Stock Units (RSUs) and Stock Appreciation Rights (SARs).
- Market Impact: The transaction is a standard grant and is expected to have a neutral impact on the stock.
Company Information
| Field | Value |
|---|---|
| Company | GARTNER INC |
| Ticker Symbol | IT |
| CIK | 0000749251 |
| Industry | SERVICES-MANAGEMENT SERVICES |
Insider Information
| Field | Value |
|---|---|
| Name | Kim Thomas Sang |
| CIK | 0001969228 |
| Title/Position | EVP, Chief Legal Officer |
| Relationship | Officer |
Transaction Details
This filing reports two separate derivative grants. The primary details below are for the RSU grant, with combined analysis provided for context.
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2026-02-05 |
| Transaction Code | A (Award) |
| Security Type | Restricted Stock Units |
| Shares Involved | 2,687 |
| Price Per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 2,687 (of this security) |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
Note: Analysis combines the 2,687 RSUs and 16,113 SARs grants for a complete view of the compensation event.
| Metric | Value |
|---|---|
| Transaction Value | $0 (Grants reported at zero value) |
| Shares Transacted | 18,800 (underlying shares) |
| % of Shares Outstanding | 0.026% |
| Post-Transaction Ownership | 18,800 (in new derivative securities) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a large-cap company with an $11.27 billion market capitalization, an equity grant of this size is a routine part of executive compensation and not financially material to the company's overall valuation.
- Ownership Concentration: This grant establishes a new holding for the insider in these specific securities. The total shares underlying the grant are a very small fraction of the total shares outstanding.
- Dilution Impact: The potential issuance of 18,800 shares upon vesting and/or exercise represents a negligible 0.026% dilution against the 72.08 million shares outstanding. This level of dilution is insignificant and well within the norms for executive compensation plans.
- Transaction Significance: The transaction's value as a percentage of market cap is effectively zero at grant, and the shares involved are less than 0.1% of shares outstanding. Therefore, the transaction has low significance.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: Equity grants to executives are a standard and expected business practice for aligning incentives. They do not signal new information to the market that would warrant a price reaction.
Volume & Sentiment
- Expected Volume Impact: None. This is a non-market transaction and will not directly impact trading volume.
- Sentiment Indicator: Neutral. This filing is informational and reflects standard corporate governance regarding compensation.
Additional Context
Transaction Notes
- The filing includes two grants: 2,687 performance-based RSUs and 16,113 SARs.
- Vesting Schedule: Both grants have a four-year vesting schedule, commencing in 2026 for the RSUs and 2027 for the SARs, encouraging long-term alignment with the company's performance.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
